ProShare Advisors
VERA icon

ProShare Advisors’s Vera Therapeutics VERA Stock Holding History

ProShare Advisors’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$489K Sell
12,155
-783
-6% -$33.7K ﹤0.01% 1080
2025
Q4 		$655K Buy
12,938
+1,864
+17% +$66.2K ﹤0.01% 994
2025
Q3 		$322K Sell
11,074
-1,861
-14% -$43K ﹤0.01% 1371
2025
Q2 		$305K Buy
12,935
+247
+2% +$5.55K ﹤0.01% 1432
2025
Q1 		$305K Sell
12,688
-2,799
-18% -$89.9K ﹤0.01% 1401
2024
Q4 		$655K Buy
15,487
+4,883
+46% +$216K ﹤0.01% 1123
2024
Q3 		$469K Buy
10,604
+1,855
+21% +$70.4K ﹤0.01% 1174
2024
Q2 		$317K Sell
8,749
-2,136
-20% -$84.7K ﹤0.01% 1250
2024
Q1 		$469K Buy
+10,885
New +$388K ﹤0.01% 1130

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return